Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Patricia Tonin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Anatomy

Geographic Areas

Procedures

Chromosome Mapping

Physiology

Devices

Oligonucleotide Array Sequence Analysis

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Quinn Michael C J; Filali-Mouhim Abdelali; Provencher Diane M; Mes-Masson Anne-Marie; Tonin Patricia N
Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Manderson Emily N; Birch Ashley H; Shen Zhen; Mes-Masson Anne-Marie; Provencher Diane; Tonin Patricia N
Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
Tonin Patricia N
Thematic issue on the molecular biology of hereditary ovarian cancer. Preface.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patricia Tonin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Quinn Michael C J; Filali-Mouhim Abdelali; Provencher Diane M; Mes-Masson Anne-Marie; Tonin Patricia N
Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Molecular carcinogenesis 2009;48(7):648-61.
2009: Manderson Emily N; Birch Ashley H; Shen Zhen; Mes-Masson Anne-Marie; Provencher Diane; Tonin Patricia N
Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):513-25.
2009: Tonin Patricia N
Thematic issue on the molecular biology of hereditary ovarian cancer. Preface.
Molecular oncology 2009;3(2):94-6.
2009: Quinn Michael C J; Wilson Daniel J; Young Fiona; Dempsey Adam A; Arcand Suzanna L; Birch Ashley H; Wojnarowicz Paulina M; Provencher Diane; Mes-Masson Anne-Marie; Englert David; Tonin Patricia N
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profiles.
Journal of translational medicine 2009;7():55.
2009: Le Page Cécile; Puiffe Marie-Line; Meunier Liliane; Zietarska Magdalena; de Ladurantaye Manon; Tonin Patricia N; Provencher Diane; Mes-Masson Anne-Marie
BMP-2 signaling in ovarian cancer and its association with poor prognosis.
Journal of ovarian research 2009;2():4.
2008: Wojnarowicz P M; Breznan A; Arcand S L; Filali-Mouhim A; Provencher D M; Mes-Masson A-M; Tonin P N
Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(5):963-75.
2008: Le Page Cécile; Ouellet Véronique; Quinn Michael C J; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(4):913-20.
2008: Arcand Suzanna L; Maugard Christine M; Ghadirian Parviz; Robidoux André; Perret Chantal; Zhang Phil; Fafard Eve; Mes-Masson Anne-Marie; Foulkes William D; Provencher Diane; Narod Steven A; Tonin Patricia N
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Breast cancer research and treatment 2008;108(3):399-408.
2008: Tulandi Togas; Al-Sunaidi Mohammed; Arseneau Jocelyne; Tonin Patricia N; Arcand Suzanna L
Calcified tissue of fetal origin in utero.
Fertility and sterility 2008;89(1):217-8.
2008: Birch Ashley H; Quinn Michael C J; Filali-Mouhim Ali; Provencher Diane M; Mes-Masson Anne-Marie; Tonin Patricia N
Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
Molecular carcinogenesis 2008;47(1):56-65.
2008: Ouellet Véronique; Ling Tak Hay; Normandin Karine; Madore Jason; Lussier Christian; Barrès Véronique; Bachvarov Dimcho; Rancourt Claudine; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.
BMC cancer 2008;8():346.
2008: Novak David J; Chen Long Qi; Ghadirian Parviz; Hamel Nancy; Zhang Phil; Rossiny Vanessa; Cardinal Guy; Robidoux André; Tonin Patricia N; Rousseau Francois; Narod Steven A; Foulkes William D
Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women.
BMC cancer 2008;8():239.
2008: Cody Neal Al; Zietarska Magdalena; Filali-Mouhim Ali; Provencher Diane M; Mes-Masson Anne-Marie; Tonin Patricia N
Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.
BMC medical genomics 2008;1():34.
2008: Ouellet Véronique; Zietarska Magdalena; Portelance Lise; Lafontaine Julie; Madore Jason; Puiffe Marie-Line; Arcand Suzanna L; Shen Zhen; Hébert Josée; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
Characterization of three new serous epithelial ovarian cancer cell lines.
BMC cancer 2008;8():152.
2008: Cavallone Luca; Arcand Suzanna L; Maugard Christine; Ghadirian Parviz; Mes-Masson Anne-Marie; Provencher Diane; Tonin Patricia N
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
BMC cancer 2008;8():96.
2007: Puiffe Marie-Line; Le Page Cécile; Filali-Mouhim Abdelali; Zietarska Magdalena; Ouellet Véronique; Tonin Patricia N; Chevrette Mario; Provencher Diane M; Mes-Masson Anne-Marie
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
Neoplasia (New York, N.Y.) 2007;9(10):820-9.
2007: Zietarska Magdalena; Maugard Christine M; Filali-Mouhim Abdelali; Alam-Fahmy Mona; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
Molecular carcinogenesis 2007;46(10):872-85.
2007: Ouellet Véronique; Le Page Cécile; Madore Jason; Guyot Marie-Claude; Barrès Véronique; Lussier Christian; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
An apoptotic molecular network identified by microarray: on the TRAIL to new insights in epithelial ovarian cancer.
Cancer 2007;110(2):297-308.
2007: Tischkowitz Marc; Xia Bing; Sabbaghian Nelly; Reis-Filho Jorge S; Hamel Nancy; Li Guilan; van Beers Erik H; Li Lili; Khalil Tayma; Quenneville Louise A; Omeroglu Atilla; Poll Aletta; Lepage Pierre; Wong Nora; Nederlof Petra M; Ashworth Alan; Tonin Patricia N; Narod Steven A; Livingston David M; Foulkes William D
Analysis of PALB2/FANCN-associated breast cancer families.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(16):6788-93.
2007: Benoît Marie-Hélène; Hudson Thomas J; Maire Georges; Squire Jeremy A; Arcand Suzanna L; Provencher Diane; Mes-Masson Anne-Marie; Tonin Patricia N
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
International journal of oncology 2007;30(1):5-17.
2007: Cody N A L; Ouellet V; Manderson E N; Quinn M C J; Filali-Mouhim A; Tellis P; Zietarska M; Provencher D M; Mes-Masson A-M; Chevrette M; Tonin P N
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
Oncogene 2007;26(4):618-32.
2007: Tonin Patricia N; Maugard Christine M; Perret Chantal; Mes-Masson Anne-Marie; Provencher Diane M
A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.
Familial cancer 2007;6(4):491-7.
2006: Ouellet Véronique; Le Page Cécile; Guyot Marie-Claude; Lussier Christian; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
SET complex in serous epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(9):2119-26.
2006: Oros K K; Ghadirian P; Maugard C M; Perret C; Paredes Y; Mes-Masson A-M; Foulkes W D; Provencher D; Tonin P N
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
Clinical genetics 2006;70(4):320-9.
2006: Tonin Patricia N
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada]
Bulletin du cancer 2006;93(9):841-6.
2006: Ouellet Véronique; Guyot Marie-Claude; Le Page Cécile; Filali-Mouhim Abdelali; Lussier Christian; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(3):599-607.
2006: Le Page Cécile; Ouellet Véronique; Madore Jason; Hudson Thomas J; Tonin Patricia N; Provencher Diane M; Mes-Masson Anne-Marie
From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;118(7):1750-8.
2006: Le Page C; Ouellet V; Madore J; Ren F; Hudson T J; Tonin P N; Provencher D M; Mes-Masson A-M
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.
British journal of cancer 2006;94(3):436-45.
2006: Oros Kathleen K; Leblanc Guy; Arcand Suzanna L; Shen Zhen; Perret Chantal; Mes-Masson Anne-Marie; Foulkes William D; Ghadirian Parviz; Provencher Diane; Tonin Patricia N
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
BMC medical genetics 2006;7():23.
2005: Arcand Suzanna L; Provencher Diane; Mes-Masson Anne-Marie; Tonin Patricia N
OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer.
International journal of oncology 2005;27(5):1315-20.
2005: Foulkes William D; Hamel Nancy; Oros Kathleen Klein; Tonin Patricia N
BRCA mutations and ductal carcinoma in situ.
JAMA : the journal of the American Medical Association 2005;294(5):553-4.
2005: Ouellet Véronique; Provencher Diane M; Maugard Christine M; Le Page Cécile; Ren Fengge; Lussier Christian; Novak Jaroslav; Ge Bing; Hudson Thomas J; Tonin Patricia N; Mes-Masson Anne-Marie
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.
Oncogene 2005;24(29):4672-87.
2005: Presneau Nadège; Dewar Ken; Forgetta Vince; Provencher Diane; Mes-Masson Anne-Marie; Tonin Patricia N
Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
Molecular carcinogenesis 2005;43(3):141-54.
2005: Presneau Nadège; Shen Zhen; Provencher Diane; Mes-Masson Anne-Marie; Tonin Patricia N
Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors.
International journal of oncology 2005;26(6):1621-7.
2004: Samouëlian V; Maugard C M; Jolicoeur M; Bertrand R; Arcand S L; Tonin P N; Provencher D M; Mes-Masson A-M
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
Cancer chemotherapy and pharmacology 2004;54(6):497-504.
2004: Oros Kathleen K; Ghadirian Parviz; Greenwood Celia M T; Perret Chantal; Shen Zhen; Paredes Yosabeth; Arcand Suzanna L; Mes-Masson Anne-Marie; Narod Steven A; Foulkes William D; Provencher Diane; Tonin Patricia N
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.
International journal of cancer. Journal international du cancer 2004;112(3):411-9.
2004: Arcand Suzanna L; Mes-Masson Anne-Marie; Provencher Diane; Hudson Thomas J; Tonin Patricia N
Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogeneously staining region.
Molecular carcinogenesis 2004;41(1):17-38.
2004: Ghadirian Parviz; Lubinski Jan; Lynch Henry; Neuhausen Susan L; Weber Barbara; Isaacs Claudine; Baruch Ruth-Gershoni; Randall Susan; Ainsworth Peter; Friedman Eitan; Horsman Douglas; Tonin Patricia; Foulkes William D; Tung Nadine; Sun Ping; Narod Steven A
Smoking and the risk of breast cancer among carriers of BRCA mutations.
International journal of cancer. Journal international du cancer 2004;110(3):413-6.
2003: Presneau Nadege; Manderson Emily N; Tonin Patricia N
The quest for a tumor suppressor gene phenotype.
Current molecular medicine 2003;3(7):605-29.
2003: Presneau Nadège; Mes-Masson Anne-Marie; Ge Bing; Provencher Diane; Hudson Thomas J; Tonin Patricia N
Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
Oncogene 2003;22(10):1568-79.
2002: Manderson Emily N; Presneau Nadège; Provencher Diane; Mes-Masson Anne-Marie; Tonin Patricia N
Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Molecular carcinogenesis 2002;34(2):78-90.
2002: Laaziri Khalid; Sutton M; Ghadirian P; Scott A S; Paradis A J; Tonin P N; Foulkes W D
Is there a correlation between the structure of hair and breast cancer or BRCA1/2 mutations?
Physics in medicine and biology 2002;47(10):1623-32.
2002: Manderson Emily N; Mes-Masson Anne-Marie; Novak Jaroslav; Lee Peter D; Provencher Diane; Hudson Thomas J; Tonin Patricia N
Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
Genome research 2002;12(1):112-21.
2001: Tonin P N; Hudson T J; Rodier F; Bossolasco M; Lee P D; Novak J; Manderson E N; Provencher D; Mes-Masson A M
Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
Oncogene 2001;20(45):6617-26.
2001: Chappuis P O; Hamel N; Paradis A J; Deschênes J; Robidoux A; Potvin C; Cantin J; Tonin P; Ghadirian P; Foulkes W D
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.
Clinical genetics 2001;59(6):418-23.
2001: Tonin P N; Perret C; Lambert J A; Paradis A J; Kantemiroff T; Benoît M H; Martin G; Foulkes W D; Ghadirian P
Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.
International journal of cancer. Journal international du cancer 2001;95(3):189-93.
2001: Chappuis P O; Hamel N; Paradis A J; Deschênes J; Tonin P N; Ghadirian P; Foulkes W D
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Journal of the National Cancer Institute 2001;93(2):152-4.
2001: Manning A P; Abelovich D; Ghadirian P; Lambert J A; Frappier D; Provencher D; Robidoux A; Peretz T; Narod S A; Mes-Masson A M; Foulkes W D; Wang T; Morgan K; Fujiwara T M; Tonin P N
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families.
Human heredity 2001;52(2):116-20.
2000: Tonin P N
Genes implicated in hereditary breast cancer syndromes.
Seminars in surgical oncology 2000;18(4):281-6.
2000: Manderson E N; Mes-Masson A M; Provencher D; Tonin P N
Mutations in a 10-bp polyadenine repeat of transforming growth factor beta-receptor type II gene is an infrequent event in human epithelial ovarian cancer.
Clinical genetics 2000;57(2):151-3.
1999: Hamel N; Manning A; Black M J; Tonin P N; Foulkes W D
An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 1999;83(6):803-4.
1999: Tonin P N; Mes-Masson A M; Narod S A; Ghadirian P; Provencher D
Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.
Clinical genetics 1999;55(5):318-24.
1998: Tonin P N; Mes-Masson A M; Futreal P A; Morgan K; Mahon M; Foulkes W D; Cole D E; Provencher D; Ghadirian P; Narod S A
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
American journal of human genetics 1998;63(5):1341-51.
1997: Foulkes W D; Wong N; Brunet J S; Bégin L R; Zhang J C; Martinez J J; Rozen F; Tonin P N; Narod S A; Karp S E; Pollak M N
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2465-9.
1997: Karp S E; Tonin P N; Bégin L R; Martinez J J; Zhang J C; Pollak M N; Foulkes W D
Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.
Cancer 1997;80(3):435-41.
1997: Brunet J S; Narod S A; Tonin P; Foulkes W D
BRCA1 mutations and survival in women with ovarian cancer.
The New England journal of medicine 1997;336(17):1256; author reply 1256-7.
1996: Tonin P; Weber B; Offit K; Couch F; Rebbeck T R; Neuhausen S; Godwin A K; Daly M; Wagner-Costalos J; Berman D; Grana G; Fox E; Kane M F; Kolodner R D; Krainer M; Haber D A; Struewing J P; Warner E; Rosen B; Lerman C; Peshkin B; Norton L; Serova O; Foulkes W D; Garber J E
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Nature medicine 1996;2(11):1179-83.
1996: Durocher F; Tonin P; Shattuck-Eidens D; Skolnick M; Narod S A; Simard J
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.
Journal of medical genetics 1996;33(10):814-9.
1996: Bapat B; Xia L; Madlensky L; Mitri A; Tonin P; Narod S A; Gallinger S
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.
American journal of human genetics 1996;59(3):736-9.
1996: Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton M R; Narod S A
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
Nature genetics 1996;13(4):461-3.
1996: Foulkes W D; Bolduc N; Lambert D; Ginsburg O; Olien L; Yandell D W; Tonin P N; Narod S A
Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.
Journal of medical genetics 1996;33(7):534-9.
1996: Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon S J; Conway T; Tonin P; Lenoir G; Lynch H
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
JAMA : the journal of the American Medical Association 1996;275(24):1885-92.
1996: Phelan C M; Lancaster J M; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher M C; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod S A; Futreal P A
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Nature genetics 1996;13(1):120-2.
1996: Phelan C M; Larsson C; Baird S; Futreal P A; Ruttledge M H; Morgan K; Tonin P; Hung H; Korneluk R G; Pollak M N; Narod S A
The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.
Genomics 1996;34(1):63-8.
1996: Marcus J N; Watson P; Page D L; Narod S A; Lenoir G M; Tonin P; Linder-Stephenson L; Salerno G; Conway T A; Lynch H T
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
Cancer 1996;77(4):697-709.
1996: Neuhausen S L; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick M H; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King M C; Goldgar D E
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
1996: Serova O; Montagna M; Torchard D; Narod S A; Tonin P; Sylla B; Lynch H T; Feunteun J; Lenoir G M
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
American journal of human genetics 1996;58(1):42-51.
1995: Tonin P; Ghadirian P; Phelan C; Lenoir G M; Lynch H T; Letendre F; Belanger D; Monté M; Narod S A
A large multisite cancer family is linked to BRCA2.
Journal of medical genetics 1995;32(12):982-4.
1995: Rommens J M; Durocher F; McArthur J; Tonin P; LeBlanc J F; Allen T; Samson C; Ferri L; Narod S; Morgan K
Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21.
Genomics 1995;28(3):530-42.
1995: Cornelis R S; Neuhausen S L; Johansson O; Arason A; Kelsell D; Ponder B A; Tonin P; Hamann U; Lindblom A; Lalle P
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.
Genes, chromosomes & cancer 1995;13(3):203-10.
1995: Tonin P; Serova O; Lenoir G; Lynch H; Durocher F; Simard J; Morgan K; Narod S
BRCA1 mutations in Ashkenazi Jewish women.
American journal of human genetics 1995;57(1):189.
1995: Tonin P; Moslehi R; Green R; Rosen B; Cole D; Boyd N; Cutler C; Margolese R; Carter R; McGillivray B
Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
Human genetics 1995;95(5):545-50.
1994: Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc J F; Bélanger C; Dion F
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
Nature genetics 1994;8(4):392-8.
1994: Narod S A; Madlensky L; Bradley L; Cole D; Tonin P; Rosen B; Risch H A
Hereditary and familial ovarian cancer in southern Ontario.
Cancer 1994;74(8):2341-6.
1994: Tonin P; Serova O; Simard J; Lenoir G; Feunteun J; Morgan K; Lynch H; Narod S
The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.
Human molecular genetics 1994;3(9):1679-82.
1994: Green R C; Narod S A; Morasse J; Young T L; Cox J; Fitzgerald G W; Tonin P; Ginsburg O; Miller S; Jothy S
Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.
American journal of human genetics 1994;54(6):1067-77.
1994: Narod S; Tonin P; Lynch H; Watson P; Feunteun J; Lenoir G
Histology of BRCA1-associated ovarian tumours.
Lancet 1994;343(8891):236.
1993: Tonin P; Ehrenborg E; Lenoir G; Feunteun J; Lynch H; Morgan K; Zazzi H; Vivier A; Pollak M; Huynh H
The human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer.
Genomics 1993;18(2):414-7.
1993: Simard J; Feunteun J; Lenoir G; Tonin P; Normand T; Luu The V; Vivier A; Lasko D; Morgan K; Rouleau G A
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.
Human molecular genetics 1993;2(8):1193-9.
1992: Chaudhuri M M; Tonin P N; Srinivasan P R
cDNA sequence of the small subunit of the hamster ribonucleotide reductase.
Biochimica et biophysica acta 1992;1171(1):117-21.
1992: Chaudhuri M M; Tonin P N; Lewis W H; Srinivasan P R
The gene for a novel protein, a member of the protein disulphide isomerase/form I phosphoinositide-specific phospholipase C family, is amplified in hydroxyurea-resistant cells.
The Biochemical journal 1992;281 ( Pt 3)():645-50.
1989: Tonin P N; Yeger H; Stallings R L; Srinivasan P R; Lewis W H
Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
Oncogene 1989;4(9):1117-21.
1988: McClarty G A; Tonin P N; Srinivasan P R; Wright J A
Relationships between reversion of hydroxyurea resistance in hamster cells and the co-amplification of ribonucleotide reductase M2 component, ornithine decarboxylase and P5-8 genes.
Biochemical and biophysical research communications 1988;154(3):975-81.
1987: Srinivasan P R; Tonin P N; Wensing E J; Lewis W H
The gene for ornithine decarboxylase is co-amplified in hydroxyurea-resistant hamster cells.
The Journal of biological chemistry 1987;262(26):12871-8.
1987: Cocking J M; Tonin P N; Stokoe N M; Wensing E J; Lewis W H; Srinivasan P R
Gene for M1 subunit of ribonucleotide reductase is amplified in hydroxyurea-resistant hamster cells.
Somatic cell and molecular genetics 1987;13(3):221-33.
1987: Tonin P N; Stallings R L; Carman M D; Bertino J R; Wright J A; Srinivasan P R; Lewis W H
Chromosomal assignment of amplified genes in hydroxyurea-resistant hamster cells.
Cytogenetics and cell genetics 1987;45(2):102-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Patricia Tonin

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Anatomy

Geographic Areas

Procedures

Physiology

Devices

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Patricia Tonin (preview)

All Publications